Salem, CT, United States of America

Michael L Corman


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Michael L Corman

Introduction

Michael L Corman is an accomplished inventor based in Salem, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of asthma. His work is characterized by a focus on innovative chemical formulations that have the potential to improve patient outcomes.

Latest Patents

Corman holds a patent for "Substituted amino triazoles, and methods using same." This invention provides novel substituted amino triazoles of Formula (I), or a pharmaceutically acceptable salt, hydrate, or solvate thereof. The compounds developed through this patent are inhibitors of acidic mammalian chitinase (AMCase) and are particularly useful for treating asthma. The invention also outlines methods for using these compounds and compositions to treat asthma and monitor treatment effectiveness.

Career Highlights

Corman's career is marked by his role at the Institute for Drug Discovery, LLC, where he has been instrumental in advancing pharmaceutical research. His innovative approach to drug development has garnered attention in the scientific community, and his patent reflects his commitment to addressing critical health issues.

Collaborations

Throughout his career, Corman has collaborated with notable colleagues, including William M Hungerford and Adam A Golebiowski. These partnerships have contributed to the success of his research and the development of effective pharmaceutical solutions.

Conclusion

Michael L Corman's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his dedication to improving health outcomes for asthma patients. His work exemplifies the impact of inventive thinking in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…